AC Immune SA Forecast, price target & analysts
AC Immune SA Target price 2025 - Analyst rating & recommendation
AC Immune SA Classifications & Recommendation:
AC Immune SA Price Target
| Target Price | $9.18 |
| Price | $2.09 |
| Potential |
339.23%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target AC Immune SA 2026 .
The average AC Immune SA target price is $9.18.
This is
339.23%
register free of charge
$12.60
502.87%
register free of charge
$7.07
238.28%
register free of charge
|
|
| A rating was issued by 10 analysts: 9 Analysts recommend AC Immune SA to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the AC Immune SA stock has an average upside potential 2026 of
339.23%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2030
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 34.13 | 4.57 |
| 84.49% | 86.60% | |
| EBITDA Margin | -183.89% | 446.15% |
| 47.05% | 342.62% | |
| Net Margin | -186.46% | -2,148.43% |
| 49.11% | 1,052.20% |
6 Analysts have issued a sales forecast AC Immune SA 2025 . The average AC Immune SA sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an AC Immune SA EBITDA forecast 2025. The average AC Immune SA EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
6 AC Immune SA Analysts have issued a net profit forecast 2025. The average AC Immune SA net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2030
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.64 | -0.98 |
| 20.00% | 53.13% | |
| P/E | negative | |
| EV/Sales | 6.84 |
6 Analysts have issued a AC Immune SA forecast for earnings per share. The average AC Immune SA EPS is
This results in the following potential growth metrics and future valuations:
Current AC Immune SA Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | May 01 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 03 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 14 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 15 2024 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 06 2024 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 18 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
May 01 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 03 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 14 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 15 2024 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 06 2024 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 18 2024 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
